Cargando…
Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines
BACKGROUND: Meningioma tumors arise in arachnoid membranes, and are the most reported central nervous system (CNS) tumors worldwide. Up to 20% of grade I meningioma tumors reoccur and currently predictive cancer stem cells (CSCs) markers for aggressive and drug resistant meningiomas are scarce. METH...
Autores principales: | Khan, Ishaq, Baeesa, Saleh, Bangash, Mohammed, Schulten, Hans-Juergen, Alghamdi, Fahad, Qashqari, Hanadi, Madkhali, Nawal, Carracedo, Angel, Saka, Mohamad, Jamal, Awatif, Al-Maghrabi, Jaudah, AlQahtani, Mohammed, Al-Karim, Saleh, Damanhouri, Ghazi, Saini, Kulvinder, Chaudhary, Adeel, Abuzenadah, Adel, Hussein, Deema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521079/ https://www.ncbi.nlm.nih.gov/pubmed/28736504 http://dx.doi.org/10.1186/s12935-017-0441-7 |
Ejemplares similares
-
Initial characterization of drug resistant cancer stem cells isolated from primary brain tumors (astrocytoma) cell lines generated from Saudi patients
por: Khan, Ishaq, et al.
Publicado: (2014) -
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
por: Schulten, Hans-Juergen, et al.
Publicado: (2016) -
Comprehensive molecular biomarker identification in breast cancer brain metastases
por: Schulten, Hans-Juergen, et al.
Publicado: (2017) -
In situ characterization of stem cells-like biomarkers in meningiomas
por: Alamir, Hanin, et al.
Publicado: (2018) -
Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes
por: Hussein, Deema, et al.
Publicado: (2020)